🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will address the question of whether targeting CMV antigens with...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2024-07-18
Trial ID
NCT05096481
Treatments Being Tested
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of a PEPI...
Status
Recruiting
Location
Duke University Medical Center
Start Date
2025-07-15
Trial ID
NCT05609994
Treatments Being Tested
Invasive meningococcal disease and meningococcal meningitis caused by Neiss...
Status
Completed
Location
Multiple Locations
Start Date
2016-05-12
Trial ID
NCT03714737
Treatments Being Tested
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
The purpose of this study was to evaluate the reactogenicity, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-02
Trial ID
NCT05169905
Treatments Being Tested
Primary Objective: To demonstrate the vaccine seroresponse sufficiency of ...
Status
Completed
Location
Investigational Site Number 8400012
Start Date
2019-09-03
Trial ID
NCT04084769
This research study is for subjects that are receiving a bone marrow transp...
Status
Completed
Location
Texas Childen's Hospital
Start Date
2008-03
Trial ID
NCT01611298
Treatments Being Tested
Primary Objective: To demonstrate sufficiency of the vaccine seroresponse ...
Status
Completed
Location
Investigational Site Number 8400026
Start Date
2019-10-04
Trial ID
NCT04142242
Primary objectives: To demonstrate that REPEVAX and VAXIGRIP administered ...
Status
Completed
Location
Sanofi Pasteur MSD Investigational Site
Start Date
2010-10
Trial ID
NCT01249183
Treatments Being Tested